Alberto Carlos Reino: Anticoagulation in Membranous Nephropathy – Albumin Is Not Enough
Alberto Carlos Reino, Nephrologist at Nefron SAS, shared on LinkedIn:
”Anticoagulation in Membranous Nephropathy: Albumin Is Not Enough
Yes, membranous nephropathy carries a high thrombotic risk — but serum albumin alone should not drive anticoagulation decisions.
A validated decision-analysis tool integrates both thrombotic and bleeding risk, incorporating age, kidney function, haemoglobin, bleeding history, dialysis status, and an explicit benefit–risk threshold (VTE prevented per major bleed).
This allows individualised, patient-centred decisions, rather than reflex anticoagulation.
According to KDIGO, prophylactic anticoagulation is reasonable only in patients with severe hypoalbuminemia and low bleeding risk.
Aspirin remains an option when bleeding risk is high.
Despite their popularity, DOACs remain insufficiently studied in nephrotic syndrome, where heavy proteinuria may alter both safety and efficacy.
Bottom line:
In MN, anticoagulation should be risk-stratified, evidence-based, and individualised — not protocol-driven.”
Find the Decision Analysis here.
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies
-
Sep 30, 2026, 12:52Paul Watton: Could Repetitive Head Impacts Leave a Molecular Memory?
-
Sep 30, 2026, 12:41The Journey to ISTH 2027 Starts in Vancouver
-
Sep 30, 2026, 11:36Basit Ali: A Closer Look at CT Venography